RxSight, Inc. (RXST) Current Ratio
- Current ratio · latest quarter: Value 4.07×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 4.07× | Current assets / current liabilities. $327.40M ÷ $80.44M ≈ 4.07× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 327.40M USD | Assets, Current |
| Current obligations | 80.44M USD | Liabilities, Current |
| Cash and equivalents | 13.35M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 18.52M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | 37.12M USD | Inventory, Net |
| Payables | 6.34M USD | Accounts Payable, Current |
| Borrowing debt due within one year | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $327.40M | $80.44M | $13.35M | (m) | $18.52M | $37.12M | $6.34M | (m) | 4.07× |
| 2026-03-31 | $279.23M | $27.38M | $17.57M | (m) | $22.44M | $34.87M | $7.12M | (m) | 10.20× |
| 2025-12-31 | $287.46M | $26.25M | $19.95M | (m) | $23.38M | $31.56M | $5.30M | (m) | 10.95× |
| 2025-09-30 | $283.88M | $22.29M | $29.63M | (m) | $24.15M | $28.95M | $3.38M | (m) | 12.74× |
| 2025-06-30 | $283.87M | $20.38M | $40.35M | (m) | $28.06M | $25.06M | $3.35M | (m) | 13.93× |
| 2025-03-31 | $288.41M | $22.74M | $28.00M | (m) | $30.96M | $23.57M | $7.11M | (m) | 12.68× |
| 2024-12-31 | $293.82M | $25.88M | $16.71M | (m) | $30.05M | $22.01M | $4.54M | (m) | 11.36× |
| 2024-09-30 | $286.77M | $22.64M | $16.72M | (m) | $25.37M | $21.67M | $4.58M | (m) | 12.67× |
| 2024-06-30 | $281.22M | $19.62M | $24.45M | (m) | $25.72M | $19.44M | $5.09M | (m) | 14.33× |
| 2024-03-31 | $168.56M | $18.33M | $32.65M | (m) | $21.55M | $18.70M | $5.06M | (m) | 9.20× |
| 2023-12-31 | $168.41M | $20.90M | $9.69M | (m) | $20.28M | $17.42M | $3.86M | (m) | 8.06× |
| 2023-09-30 | $167.95M | $18.94M | $9.86M | (m) | $15.24M | $18.92M | $4.11M | (m) | 8.87× |
| 2023-06-30 | $180.44M | $16.57M | $8.75M | (m) | $13.29M | $17.95M | $4.00M | (m) | 10.89× |
| 2023-03-31 | $187.67M | $14.88M | $11.01M | (m) | $12.67M | $18.07M | $3.72M | (m) | 12.62× |
| 2022-12-31 | $134.56M | $17.24M | $11.83M | (m) | $10.96M | $14.84M | $2.60M | (m) | 7.81× |
| 2022-09-30 | $139.16M | $16.37M | $8.91M | (m) | $9.02M | $15.34M | $4.17M | (m) | 8.50× |
| 2022-06-30 | $149.93M | $13.00M | $24.00M | (m) | $6.88M | $11.62M | $3.28M | (m) | 11.54× |
| 2022-03-31 | $161.15M | $10.66M | $24.13M | (m) | $5.63M | $8.49M | $2.59M | (m) | 15.12× |
| 2021-12-31 | $176.29M | $11.08M | $24.36M | (m) | $4.86M | $8.03M | $1.69M | (m) | 15.92× |
| 2021-09-30 | $186.34M | $9.18M | $68.28M | (m) | $4.36M | $9.44M | $1.69M | (m) | 20.31× |
| 2021-06-30 | $75.55M | $11.10M | $41.73M | (m) | $3.94M | $8.54M | $2.34M | (m) | 6.80× |
| 2020-12-31 | $81.50M | $11.60M | $13.99M | (m) | $2.87M | $8.29M | $1.13M | (m) | 7.03× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Innovative Eyewear Inc (LUCY) | United States | $0.008B | |
| STAAR SURGICAL CO (STAA) | United States | $0.957B | 362.70 |
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |